[86] I. Z. Shirgaonkar, S. Lanthier, and A. Kamen, “Acoustic cell filter: a proven cell

retention technology for perfusion of animal cell cultures,” Biotechnol. Adv.,

vol. 22, no. 6, pp. 433–444, 2004.

[87] Z. Wang, “Two approaches for cell retention in perfusion culture systems,”

Cleveland State University, 2009.

[88] M. C. Dalm, S. M. Cuijten, W. M. van Grunsven, J. Tramper, and D. E. Martens,

“Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bior-

eactor: part I. Cell density, viability, and cell-cycle distribution,” Biotechnol.

Bioeng., vol. 88, no. 5, pp. 547–557, Dec. 2004.

[89] L. E. Gallo-Ramirez, A. Nikolay, Y. Genzel, and U. Reichl, “Bioreactor concepts

for cell culture-based viral vaccine production,” Expert Rev. Vaccines, vol. 14,

no. 9, pp. 1181–1195, 2015.

[90] W. Whitford, “Using disposables in cell-culture–based vaccine production,”

BioProcess Int., vol. 8, 2010.

ABBREVIATIONS

AAV

Adeno-associated virus

AD5

Adenovirus 5

AGE1.CR

Avian duck cells

ATF

Alternating tangential flow filtration

CAR T-cell

Chimeric antigen receptor T cells

CHIKV

Chikungunya virus

CHO

Chinese hamster ovary

CIP

Clean in place

COVID-19

Coronavirus disease 2019

CRD

Cell retention device

CSTR

Continuous stirred tank reactor

DIP

Defective interfering particle

DNA

Deoxyribonucleic acid

DSP

Downstream processing

E&L

Extractables and leachables

EMA

European Medicines Agency

FASTEC

Frozen accelerated seed train for execution of a campaign

FDA

Food and Drug Administration

GMP

Good manufacturing practice

HA

Hemagglutinin

HAU

Hemagglutinin units

HAV

Hepatitis A virus

HCD

High cell density

HCV

Hepatitis C virus

HFBR

Hollow fiber bioreactor

HEK293

Human embryonic kidney

HIV

Human immunodeficiency virus

Huh7.5

Human hepatocellular carcinoma cells

IAV

Influenza A virus

IPV

Inactivated polio virus

172

Bioprocessing of Viral Vaccines